Net reductive elimination (RE) of MeX (X = halide or pseudo-halide: Cl−, CF3CO2−, HSO4−, OH−) is an important step during Pt-catalyzed hydrocarbon functionalization. Developing Rh(I/III)-based catalysts for alkane functionalization is an attractive alternative to Pt-based systems, but very few examples of RE of alkyl halides and/or pseudo-halides from RhIII complexes have been reported. Here, we compare the influence of the ligand donor strength on the thermodynamic potentials for oxidative addition and reductive functionalization using [tBu3terpy]RhCl (1) {tBu3terpy = 4,4′,4′′-tri-tert-butylpyridine} and [(NO2)3terpy]RhCl (2) {(NO2)3terpy = 4,4′,4′′-trinitroterpyridine}. Complex 1 oxidatively adds MeX {X = I−, Cl−, CF3CO2− (TFA−)} to afford [tBu3terpy]RhMe(Cl)(X) {X = I− (3), Cl− (4), TFA− (5)}. By having three electron-withdrawing NO2 groups, complex 2 does not react with MeCl or MeTFA, but reacts with MeI to yield [(NO2)3terpy]RhMe(Cl)(I) (6). Heating 6 expels MeCl along with a small quantity of MeI. Repeating this experiment but with excess [Bu4N]Cl exclusively yields MeCl, while adding [Bu4N]TFA yields a mixture of MeTFA and MeCl. In contrast, 3 does not reductively eliminate MeX under similar conditions. DFT calculations successfully predict the reaction outcome by complexes 1 and 2. Calorimetric measurements of [tBu3terpy]RhI (7) and [tBu3terpy]RhMe(I)2 (8) were used to corroborate computational models. Finally, the mechanism of MeCl RE from 6 was investigated via DFT calculations, which supports a nucleophilic attack by either I− or Cl− on the Rh–CH3 bond of a five-coordinate Rh complex.
Accurate prediction of aqueous solubility (logS) is a cornerstone of drug development, influencing bioavailability, pharmacokinetics, and therapeutic efficacy. Traditional models, such as ESOL, often exhibit limited accuracy across diverse chemical datasets, whereas Artificial Neural Networks (ANNs) offer a robust alternative by capturing complex non-linear relationships in molecular descriptors derived from SMILES representations. This study evaluates the performance of various ANN architectures against baseline models, including Random Forest (RF) and Linear Regression (LR), demonstrating the superior accuracy of ANNs, which achieved the lowest mean error and most consistent error distribution. Nonetheless, model performance was influenced by the logS range and architectural complexity, with deeper networks prone to overfitting and simpler architectures susceptible to underfitting. These findings position ANNs as powerful tools for solubility prediction, underscoring the importance of balanced model design and expanded datasets to enhance generalization. AI-driven approaches offer transformative potential to accelerate drug discovery, reduce costs, and optimize therapeutic outcomes.
Accurately predicting chemical bioactivity across large and structurally diverse chemical spaces remains a central challenge in computational toxicology and molecular design. This work presents a unified framework that systematically benchmarks three complementary modeling strategies for predicting PercentToxCast, an aggregate bioactivity index derived from the U.S. EPA ToxCast program. We integrate twenty seven physicochemical and topological descriptors with standardized three dimensional molecular renderings generated from RDKit conformers and evaluate descriptor based learning, multiview image based deep learning, and multimodal fusion of numerical and image derived features. Across 7,211 compounds, gradient boosted descriptor models deliver the strongest generalization, with CatBoost achieving a hold out R 2 of 0.398 and providing interpretable feature attributions that highlight hydrophobicity, polarity, and electronic structure as dominant contributors to broad assay engagement. A six view convolutional neural network captures geometric and steric information but attains lower external performance (R 2 of 0.217), indicating that image derived structure alone does not fully encode the physicochemical determinants of bioactivity. Multimodal fusion produces extremely strong cross validated performance but yields only modest hold out gains (R 2 of 0.241 to 0.259), revealing overfitting challenges associated with the high dimensional fused representation. This study establishes one of the first rigorously controlled evaluations of descriptor, image, and fused feature spaces for broad bioactivity modeling and demonstrates that descriptors remain the most informative single modality while image based geometry provides complementary but underexploited structural cues. By unifying these approaches within a transparent and reproducible benchmark, this work defines clear performance baselines and identifies key methodological limitations that must be addressed for next generation multimodal architectures. These findings provide a foundation for chemically intelligent models that integrate three dimensional structure with physicochemical properties to advance predictive toxicology, risk assessment, and data driven molecular design.